Login
  • In Depth
  • Earnings
    Search Calendar Annual Comparison Quarterly Comparison Quarterly Range Growth Rate Sector View Earnings Averages P/E Ratio Annual Fiscal Year Dividend Frequency
  • Stocks
    Annual Returns 52 Week High/Low Advanced Search Advanced Screen 52 Wk HL Screen Financial Ratios Indexes Sectors Market Updates IPOs SEC Filings Market Cap
  • Funds
    Mutual Funds
    Funds - Family
    Q&A - Fund Family
    Q&A - Date
    Performance By Category
    Performance Screen
    Alpha Screen
    Time Period Screen
    52 Wk Mutual Funds HL Screen
    Manager Database
    ETFs
    Funds - Family
    Performance By Category
    Performance Screen
    Alpha Screen
    Time Period Screen
    52 Wk ETF HL Screen
  • Economy
    U.S.        - Feed Europe  - Feed U.S.        - Chart Europe  - Chart Currencies
  • Books
  • Weekly Review
  • Log In Sign Up
Breaking News
FactSet Research   Lennar   FedEx Corp   Scholastic   Darden Restaurants   Cracker Barrel   Hain Celestial   Dave & Buster’s   Designer Brands  
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
  • Sector
  • Technology
  • Health Care
  • Transportation
  • Manufacturing
  • Popular Earnings
  • Deutsche Bank
  • Adobe
  • Google
  • Apple
  • Microsoft
  • Facebook
  • General Electric
  • Amazon
  • Boeing
  • Delta Airlines

Market Updates

Amedisys agreed to merge with a subsidiary of UnitedHealth Group, upending its plan to just six weeks ago. 

The home-healthcare, hospice and high-acuity care provider accepted an all-cash $101 a share or $3.29 billion offer from Optum. 

The merger agreement is conditional based on regulatory approval and shareholder approval and customary closing conditions. 

On May 3, Amedisys and Option Care Health agreed to combine in an all-stock deal that valued Amedisys at $3.6 billion or $97.38 a share. 

On June 5, Optum made an unsolicited offer to acquire Amedisys for $100 a share.

Amedisys board of directors accepted a slightly lower but all-cash deal. 

Compensation committee approved one-time equity award grants of time-based restricted stock units that vest ratably over three years. 

Amedisys CEO Richard Ashworth will receive $2.5 million grant date value, and CFO Scott Ginn will receive $1.5 million grant date value, effective from the date of merger in exchange for not agreeing to leave the company for six months after the completion of the merger. 

 


26 Jun, 2023

     

Annual Returns

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Earnings

Company Ticker 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

Custom Solutions

  • Portfolio Management
  • Strategy Analysis
  • Data Feed Integration
  • Investment Process Evaluator

Advertisers

  • Sponsorship
  • Preferred Listing
  • Newsletter Placement
  • Lead Generator

Newsletter

  • Sign Up
  • Monthly Performance Update

Investor

  • Profile
  • Watch List
  • Portfolio

Site Pages

  • About Us
  • Contact Us
  • User Agreement
  • Subscribe
  • Newsletter
  • API and News Feeds

© Since 2000 ticker.com All Rights Reserved



Mutual Fund and ETF profiles, Manager Interviews Tickerfunds.com
Global Financial News
123jump.com
India Business News, Stocks and Funds
Niveshak.in
Worldwide Trade Shows and Conferences
EventsXPO.com
Non-fiction Books, Booklists, Authors, Interviews Readara.com
Land and Home Buyers, Sellers, and Service Providers Zacres.com